Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AIM ImmunoTech Inc. (AIM)

  • Business News
  • Dec. 10, 2025, 14:00 UTC
  • 16
  • 1 comments

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Market reaction Comment Full text

Owlet Inc. (OWLT)

  • Business News
  • Dec. 10, 2025, 14:00 UTC
  • 15
  • 1 comments

Owlet Launches Owlet360™ in the UK and Ireland, Bringing Data-Driven Reassurance to More Families

Market reaction Comment Full text

Anixa Biosciences Inc. (ANIX)

  • Business News
  • Dec. 10, 2025, 14:00 UTC
  • 14
  • 1 comments

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025

Market reaction Comment Full text

Jaguar Health Inc. (JAGX)

  • Business News
  • Dec. 10, 2025, 14:00 UTC
  • 16
  • 1 comments

FDA Approves Renewal of Canalevia-CA1, Jaguar Healths Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Market reaction Comment Full text

OneMedNet Inc. (ONMD)

  • Business News
  • Dec. 10, 2025, 13:50 UTC
  • 14
  • 1 comments

OneMedNet Reports Strong Momentum and Industry Excitement at RSNA

Market reaction Comment Full text

Sanara Medtech Inc (SMTI)

  • Business News
  • Dec. 10, 2025, 13:37 UTC
  • 17
  • 1 comments

Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™

Market reaction Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Business News
  • Dec. 10, 2025, 13:30 UTC
  • 15
  • 1 comments

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

Market reaction Comment Full text

Veru Inc. (VERU)

  • Business News
  • Dec. 10, 2025, 13:30 UTC
  • 14
  • 1 comments

Veru to Report Fiscal Year 2025 Financial Results on December 17th

Market reaction Comment Full text

Icecure Medical Ltd (ICCM)

  • Business News
  • Dec. 10, 2025, 13:30 UTC
  • 13
  • 1 comments

IceCures ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting

Market reaction Comment Full text

Journey Medical Corporation (DERM)

  • Business News
  • Dec. 10, 2025, 13:30 UTC
  • 12
  • 1 comments

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology

Market reaction Comment Full text
  • Previous
  • 358
  • 359
  • 360
  • 361
  • 362
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2315)
  • SEC News(190439)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124852)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin